Background
Scorpion stings are a major public health problem in many underdeveloped tropical countries, especially Sahelian Africa, South India, the Middle East, Mexico, and South Latin America. The estimated annual number of scorpion stings is 1.2 million leading to 3250 deaths (0.27%).[1] For every person killed by a poisonous snake, 10 are killed by a poisonous scorpion. In Mexico, 1000 deaths from scorpion stings occur per year. In the United States, only 4 deaths in 11 years have occurred as a result of scorpion stings. Furthermore, scorpions can be found outside their normal range of distribution, that is when they crawl into luggage, boxes, containers, or shoes and are unwittingly transported home via human travelers.
A scorpion has a flattened elongated body and can easily hide in cracks. It has 4 pairs of legs, a pair of claws, and a segmented tail that has a poisonous spike at the end. Scorpions vary in size from 1-20 cm in length.
Centruroides limbatus, identified by Scott Stockwell, PhD. A small barb at the base of the stinger may be helpful in identifying Centruroides or Tityus species, although its presence is variable. Photo by Sean Bush, MD. Out of 1500 scorpion species, 50 are dangerous to humans. Scorpion stings cause a wide range of conditions, from severe local skin reactions to neurologic, respiratory, and cardiovascular collapse. Envenomation from most scorpions results in a simple, painful, local reaction that can be treated with analgesics, antihistamines, and symptomatic/supportive care. This article focuses on scorpions that generally are considered more dangerous to humans.
Almost all of these lethal scorpions, except the Hemiscorpius species, belong to the scorpion family called the Buthidae. The Buthidae family is characterized by a triangular-shaped sternum, as opposed to the pentagonal-shaped sternum found in the other 5 scorpion families.
Scorpions from the family Buthidae (which includes almost all of the potentially lethal scorpions) generally can be identified by the triangular sternal plate. In other families of scorpions, this feature is more square or pentagonal. Photo by Sean Bush, MD. In addition to the triangular-shaped sternum, poisonous scorpions also tend to have weak-looking pincers, thin bodies, and thick tails, as opposed to the strong heavy pincers, thick bodies, and thin tails seen in nonlethal scorpions.
Centruroides species. Note the slender pincers generally characteristic of scorpions from the family Buthidae. Photo by Sean Bush, MD. The lethal members of the Buthidae family include the genera of Buthus, Parabuthus, Mesobuthus, Tityus, Leiurus, Androctonus, and Centruroides. These lethal scorpions are found generally in the given distribution:
- Buthus - Mediterranean area, from Spain to the Middle East
- Parabuthus - Western and Southern Africa
- Mesobuthus – Throughout Asia
- Parabuthus - Western and southern Africa
- Buthotus (ie, Hottentotta) - Across southern Africa to southeast Asia
- Tityus - Central America, South America, and the Caribbean
- Leiurus - Northern Africa and the Middle East
- Androctonus - Northern Africa to Southeast Asia
- Centruroides - Southern United States, Mexico, Central America, and the Caribbean (Centruroides exilicauda is found in the Baja California peninsula of Mexico and Centruroides sculpturatus is found in the state of Sonora, Mexico and the southwestern United States, primarily Arizona and small parts of Utah, New Mexico, Nevada, and California.) The accepted taxonomy of the bark scorpion has changed over time. Either C exilicauda or C sculpturatus have been accepted at various times. However, recent evidence from biochemical, genetic, and physiologic characterization of their venom suggests that they are two different species as listed above.
However, these scorpions may be found outside their natural habitat range of distribution when inadvertently transported with luggage and cargo.
In general, scorpions are not aggressive. They do not hunt for prey; they wait for it. Scorpions are nocturnal creatures; they hunt during the night and hide in crevices and burrows during the day to avoid the light. Thus, accidental human stinging occurs when scorpions are touched while in their hiding places, with most of the stings occurring on the hands and feet.
Pathophysiology
Scorpions use their pincers to grasp their prey; then, they arch their tail over their body to drive their stinger into the prey to inject their venom, sometimes more than once. The scorpion can voluntarily regulate how much venom to inject with each sting. The striated muscles in the stinger allow regulation of the amount of venom ejected, which is usually 0.1-0.6 mg. If the entire supply of venom is used, several days must elapse before the supply is replenished. Furthermore, scorpions with large venom sacs, such as the Parabuthus species, can even squirt their venom.
The venom glands are located on the tail lateral to the tip of the stinger and are composed of 2 types of tall columnar cells. One type produces the toxins, while the other produces mucus. The potency of the venom varies with the species, with some producing only a mild flu and others producing death within an hour. Generally, the venom is distributed rapidly into the tissue if it is deposited into a venous structure. Venom deposited via the intravenous route can cause symptoms only 4-7 minutes after the injection, with a peak tissue concentration in 30 minutes and an overall toxin elimination half-life of 4.2-13.4 hours through the urine. The more rapidly the venom enters the bloodstream, the higher the venom concentration in the blood and the more rapid the onset of systemic symptoms.
Scorpion venom is a water-soluble, antigenic, heterogenous mixture, as demonstrated on electrophoresis studies. This heterogeneity accounts for the variable patient reactions to the scorpion sting. However, the closer the phylogenetic relationship between the scorpions, the more similar the immunological properties. Furthermore, the various constituents of the venom may act directly or indirectly and individually or synergistically to manifest their effects. In addition, differences in the amino acid sequence of each toxin account for their differences in the function and immunology. Thus, any modifications of the amino acid sequence result in modification of the function and immunology of the toxin.
Scorpion venom may contain multiple toxins and other compounds. The venom is composed of varying concentrations of neurotoxin, cardiotoxin, nephrotoxin, hemolytic toxin, phosphodiesterases, phospholipases, hyaluronidases, glycosaminoglycans, histamine, serotonin, tryptophan, and cytokine releasers. The most important clinical effects of envenomation are neuromuscular, neuroautonomic, or local tissue effects. The primary targets of scorpion venom are voltage-dependent ion channels, of which sodium channels are the best studied. Venom toxins alter these channels, leading to prolonged neuronal activity. Many end-organ effects are secondary to this excessive excitation. Autonomic excitation leads to cardiopulmonary effects observed after some scorpion envenomations. Somatic and cranial nerve hyperactivity results from neuromuscular overstimulation. Additionally, serotonin may be found in scorpion venom and is thought to contribute to the pain associated with scorpion envenomation.
The most potent toxin is the neurotoxin, of which 2 classes exist. Both of these classes are heat-stable, have low molecular weight, and are responsible for causing cell impairment in nerves, muscles, and the heart by altering ion channel permeability.
The long-chain polypeptide neurotoxin causes stabilization of voltage-dependent sodium channels in the open position, leading to continuous, prolonged, repetitive firing of the somatic, sympathetic, and parasympathetic neurons. This repetitive firing results in autonomic and neuromuscular overexcitation symptoms, and it prevents normal nerve impulse transmissions. Furthermore, it results in release of excessive neurotransmitters such as epinephrine, norepinephrine, acetylcholine, glutamate, and aspartate. Meanwhile, the short polypeptide neurotoxin blocks the potassium channels.
The binding of these neurotoxins to the host is reversible, but different neurotoxins have different affinities. The stability of the neurotoxin is due to the 4 disulfide bridges that fold the neurotoxin into a very compact 3-dimensional structure, thus making it resistant to pH and temperature changes. However, reagents that can break the disulfide bridges can inactivate this toxin by causing it to unfold. Also, the antigenicity of this toxin is dependent on the length and number of exposed regions that are sticking out of the 3-dimensional structure.
Epidemiology
Frequency
United States
A total of 13,000 stings have been reported, with the majority being from the nonlethal scorpions. Only 1 of 30 scorpion species found in the United States is dangerous to humans. This lethal scorpion species is the straw-colored Centruroides. Less than 1% of stings from Centruroides are lethal to adults; however, 25% of children younger than 5 years who are stung die if not treated. The epidemiological features of a patient who has been envenomed show a disposition for rural areas (73%), with most of the stings occurring in the summer months between 6:00 pm and 12:00 am (49%) and a second peak from 6:00 am to 12:00 pm (30%). Both of these peaks coincide maximum human activity with maximum scorpion activity. Furthermore, the larger the scorpion population, the larger the incidence rate. Because the offending scorpion is recovered for identification in only 30% of the cases, local knowledge of the type of scorpion populating the area is useful.
In 2006, a total of 16,231 scorpion envenomations were reported to the American Association of Poison Control Centers. However, because of underreporting, this is probably an underestimation of the true number of stings.
International
Scorpion stings occur in temperate and tropical regions, especially between the latitudes of 50°N and 50°S of the equator. Furthermore, stings predominantly occur during the summer and evening times. In addition, the majority of patients are stung outside their home.
Accurate statistics on scorpion envenomation are not available. Many potentially dangerous scorpions inhabit the underdeveloped or developing world. Consequently, numerous envenomations go unreported, and true incidence is unknown. However, it has been estimated that there are 1.2 million scorpion stings per year.[1]
A recent 5-year surveillance study in Saudi Arabia found 6465 scorpion sting cases with a mean patient age of 23 years, a male-to-female ratio of 1.9, and a higher incidence of stings in the months of May through October.[2]
In Khuzestan province of Iran, 12,150 annual cases occurred, with nocturnal envenomations occurring 60.9% of the time, 39.3% stings occurring on the hands, and 37.3% stings occurring on the feet. June was the highest month for stings, at 16%, and February, the lowest at 0.6%.[3]
Mortality/Morbidity
Accurate worldwide data do not exist. The underreporting of scorpion stings is frequent because most envenomations occur in desert and jungle areas that do not have large medical facilities. Furthermore, reporting is not required.
Most deaths occur during the first 24 hours after the sting and are secondary to respiratory or cardiovascular failure.
The highest reported mortality rate is recorded in data from Mexico, with estimates as high as 1000 deaths in 1 year. In the United States, 4 deaths were reported in an 11-year period according to one source.[4] However, no deaths were reported to the American Association of Poison Control Centers from 1983 to 1999. Only one death from the Arizona bark scorpion (C sculpturatus) has been reported since 1964.[5] Ironically, the highest and lowest mortality estimates are associated with different species within the same genus of scorpion (Centruroides).
Children and elderly persons are at the greatest risk for morbidity and mortality. A smaller child, a lower body weight, and a larger ratio of venom to body weight lead to a more severe reaction. A mortality rate of 20% is reported in untreated babies, 10% in untreated school-aged children, and 1% in untreated adults.
In terms of venom lethality, the venom of Androctonus australis and Leiurus quinquestriatus are the most toxic. C sculpturatus venom is low in toxicity compared with most scorpions of medical importance.
Furthermore, patients in rural areas tend to fare worse than patients in urban areas because of the delay in getting medical help due to a longer travel time to medical centers. Fortunately, better public education, improved control of the scorpion population, increased supportive therapies, and more technologically advanced intensive care units have combined to produce a substantial decrease in mortality from these envenomations.
Race
No racial predilection exists. Any differences in individual reactions to the scorpion sting are a reflection of that individual's genetic composition rather than race.
Sex
Females are more susceptible than males to the same amount of scorpion venom because of their lower body weight.
Age
While adults are stung more often than children, children are more likely to develop a more rapid progression, increased severity of symptoms, and higher mortality because of their lower body weight.[6] Furthermore, elderly persons are more susceptible to stings because of their decreased physiologic reserves and increased debilitation.
Chippaux JP, Goyffon M. Epidemiology of scorpionism: a global apprasial. Acta Trop. 2010/08;107:71-9.
Jahan S, Mohammed Al Saigul A, Abdul Rahim Hamed S. Scorpion stings in Qassim, Saudi Arabia--a 5-year surveillance report. Toxicon. Aug 2007;50(2):302-5. [Medline].
Shahbazzadeh D, Amirkhani A, Djadid ND, Bigdeli S, Akbari A, Ahari H. Epidemiological and clinical survey of scorpionism in Khuzestan province, Iran. Toxicon. Mar 15 2009;53(4):454-9. [Medline].
Langley RL, Morrow WE. Deaths resulting from animal attacks in the United States. Wilderness Environ Med. Feb 1997;8(1):8-16. [Medline].
Boyer L, Heubner K, McNally J, Buchanan P. Death from Centruroides scorpion sting allergy [abstract]. J Toxicol Clin Toxicol. 2001;39:561-562.
Bosnak M, Ece A, Yolbas I, Bosnak V, Kaplan M, Gurkan F. Scorpion sting envenomation in children in southeast Turkey. Wilderness Environ Med. Summer 2009;20(2):118-24. [Medline].
Parma JA, Palladino CM. [Scorpion envenomation in Argentina]. Arch Argent Pediatr. Apr 2010;108(2):161-7. [Medline].
Freire-Maia L, Pinto GI, Franco I. Mechanism of the cardiovascular effects produced by purified scorpion toxin in the rat. J Pharmacol Exp Ther. Jan 1974;188(1):207-13. [Medline].
Pinto MC, Borboleta LR, Melo MB, Labarrére CR, Melo MM. Tityus fasciolatus envenomation induced cardio-respiratory alterations in rats. Toxicon. Jun 1 2010;55(6):1132-7. [Medline].
Bawaskar HS. Diagnostic cardiac premonitory signs and symptoms of red scorpion sting. Lancet. Mar 6 1982;1(8271):552-4. [Medline].
Figueiredo AB, Cupo P, Pintya AO, Caligaris F, Marin-Neto JA, Hering SE. [Assessment of myocardial perfusion and function in victims of scorpion envenomation using gated-SPECT]. Arq Bras Cardiol. Apr 2010;94(4):444-51. [Medline].
[Best Evidence] Boyer LV, Theodorou AA, Berg RA, et al. Antivenom for critically ill children with neurotoxicity from scorpion stings. N Engl J Med. May 14 2009;360(20):2090-8. [Medline]. [Full Text].
Natu VS, Kamerkar SB, Geeta K, Vidya K, Natu V, Sane S, et al. Efficacy of anti-scorpion venom serum over prazosin in the management of severe scorpion envenomation. J Postgrad Med. Oct-Dec 2010;56(4):275-80. [Medline].
Bawaskar HS, Bawaskar PH. Efficacy and safety of scorpion antivenom plus prazosin compared with prazosin alone for venomous scorpion (Mesobuthus tamulus) sting: randomised open label clinical trial. BMJ. Jan 5 2011;342:c7136. [Medline]. [Full Text].
Gupta BD, Parakh M, Purohit A. Management of scorpion sting: prazosin or dobutamine. J Trop Pediatr. Apr 2010;56(2):115-8. [Medline].
Patil SN. A retrospective analysis of a rural set up experience with special reference to dobutamine in prazosin-resistant scorpion sting cases. J Assoc Physicians India. Apr 2009;57:301-4. [Medline].
Centruroides (Scorpion) Immune F(ab')2 (Equine). Prescribing information. Accessed August 9, 2011. [Full Text].
Bouaziz M, Bahloul M, Kallel H, Samet M, Ksibi H, Dammak H, et al. Epidemiological, clinical characteristics and outcome of severe scorpion envenomation in South Tunisia: multivariate analysis of 951 cases. Toxicon. Dec 15 2008;52(8):918-26. [Medline].
Guerra CM, Carvalho LF, Colosimo EA, Freire HB. Analysis of variables related to fatal outcomes of scorpion envenomation in children and adolescents in the state of Minas Gerais, Brazil, from 2001 to 2005. J Pediatr (Rio J). Nov-Dec 2008;84(6):509-15. [Medline].
Abroug F, Ayari M, Nouira S, et al. Assessment of left ventricular function in severe scorpion envenomation: combined hemodynamic and echo-Doppler study. Intensive Care Med. Aug 1995;21(8):629-35. [Medline].
Amaral CF, Dias MB, Campolina D, Proietti FA, de Rezende NA. Children with adrenergic manifestations of envenomation after Tityus serrulatus scorpion sting are protected from early anaphylactic antivenom reactions. Toxicon. Feb 1994;32(2):211-5. [Medline].
Amaral CF, Lopes JA, Magalhaes RA, de Rezende NA. Electrocardiographic, enzymatic and echocardiographic evidence of myocardial damage after Tityus serrulatus scorpion poisoning. Am J Cardiol. Mar 15 1991;67(7):655-7. [Medline].
Amaral CF, Rezende NA. Treatment of scorpion envenoming should include both a potent specific antivenom and support of vital functions. Toxicon. Aug 2000;38(8):1005-7. [Medline].
Amitai Y, Mines Y, Aker M, Goitein K. Scorpion sting in children. A review of 51 cases. Clin Pediatr (Phila). Mar 1985;24(3):136-40. [Medline].
Bahloul M, Ben Hamida C, Chtourou K, et al. Evidence of myocardial ischaemia in severe scorpion envenomation. Myocardial perfusion scintigraphy study. Intensive Care Med. Mar 2004;30(3):461-7. [Medline].
Bawaskar HS, Bawaskar PH. Clinical profile of severe scorpion envenomation in children at rural setting. Indian Pediatr. Nov 2003;40(11):1072-5. [Medline].
Bawaskar HS, Bawaskar PH. Severe envenoming by the Indian red scorpion Mesobuthus tamulus: the use of prazosin therapy. QJM. Sep 1996;89(9):701-4. [Medline].
Bergman NJ. Scorpion sting in Zimbabwe. S Afr Med J. Feb 1997;87(2):163-7. [Medline].
Bharani AK, Sepaha GC. Myelopathy after scorpion sting. Arch Neurol. Nov 1984;41(11):1130. [Medline].
Biswal N, Mathai B, Bhatia BD. Scorpion sting envenomation: complications and management. Indian Pediatr. Aug 1993;30(8):1055-9. [Medline].
Bond GR. Antivenin administration for Centruroides scorpion sting: risks and benefits. Ann Emerg Med. Jul 1992;21(7):788-91. [Medline].
Brand A, Keren A, Kerem E, Reifen RM, Branski D. Myocardial damage after a scorpion sting: long-term echocardiographic follow-up. Pediatr Cardiol. 1988;9(1):59-61. [Medline].
Carbonaro PA, Janniger CK, Schwartz RA. Scorpion sting reactions. Cutis. Mar 1996;57(3):139-41. [Medline].
Cupo P, Jurca M, Azeedo-Marques MM, Oliveira JS, Hering SE. Severe scorpion envenomation in Brazil. Clinical, laboratory and anatomopathological aspects. Rev Inst Med Trop Sao Paulo. Jan-Feb 1994;36(1):67-76. [Medline].
Curry SC, Vance MV, Ryan PJ, Kunkel DB, Northey WT. Envenomation by the scorpion Centruroides sculpturatus. J Toxicol Clin Toxicol. 1983-1984;21(4-5):417-49. [Medline].
Das S, Nalini P, Ananthakrishnan S, Sethuraman KR, Balachander J, Srinivasan S. Cardiac involvement and scorpion envenomation in children. J Trop Pediatr. Dec 1995;41(6):338-40. [Medline].
De Rezende NA, Dias MB, Campolina D, Chavez-Olortegui C, Diniz CR, Amaral CF. Efficacy of antivenom therapy for neutralizing circulating venom antigens in patients stung by Tityus serrulatus scorpions. Am J Trop Med Hyg. Mar 1995;52(3):277-80. [Medline].
Devi CS, Reddy CN, Devi SL, et al. Defibrination syndrome due to scorpion venom poisoning. Br Med J. Feb 7 1970;1(5692):345-7. [Medline].
el-Amin EO. Issues in management of scorpion sting in children. Toxicon. Jan 1992;30(1):111-5. [Medline].
Freire-Maia L, Campos JA, Amaral CF. Approaches to the treatment of scorpion envenoming. Toxicon. Sep 1994;32(9):1009-14. [Medline].
Gateau T, Bloom M, Clark R. Response to specific Centruroides sculpturatus antivenom in 151 cases of scorpion stings. J Toxicol Clin Toxicol. 1994;32(2):165-71. [Medline].
Ghalim N, El-Hafny B, Sebti F, et al. Scorpion envenomation and serotherapy in Morocco. Am J Trop Med Hyg. Feb 2000;62(2):277-83. [Medline].
Gibly R, Williams M, Walter FG, McNally J, Conroy C, Berg RA. Continuous intravenous midazolam infusion for Centruroides exilicauda scorpion envenomation. Ann Emerg Med. Nov 1999;34(5):620-5. [Medline].
Goyffon M, Vachon M, Broglio N. Epidemiological and clinical characteristics of the scorpion envenomation in Tunisia. Toxicon. 1982;20(1):337-44. [Medline].
Gueron M, Ilia R, Sofer S. The cardiovascular system after scorpion envenomation. A review. J Toxicol Clin Toxicol. 1992;30(2):245-58. [Medline].
Gueron M, Margulis G, Ilia R, Sofer S. The management of scorpion envenomation 1993. Toxicon. Sep 1993;31(9):1071-83. [Medline].
Gueron M, Weizmann S. Catecholamine excretion in scorpion sting. Isr J Med Sci. Jul-Aug 1969;5(4):855-7. [Medline].
Ismail M. The scorpion envenoming syndrome. Toxicon. Jul 1995;33(7):825-58. [Medline].
Karnad DR. Haemodynamic patterns in patients with scorpion envenomation. Heart. May 1998;79(5):485-9. [Medline].
Kric-Dautovic S, Begovic B. Acute renal insuffiency & toxic hepatitis folowing scorpion sting. Med arh. Feb 2007;61:123-4.
Krifi MN, Kharrat H, Zghal K, et al. Development of an ELISA for the detection of scorpion venoms in sera of humans envenomed by Androctonus australis garzonii (Aag) and Buthus occitanus tunetanus (Bot): correlation with clinical severity of envenoming in Tunisia. Toxicon. Jun 1998;36(6):887-900. [Medline].
Magalhaes MM, Pereira ME, Amaral CF, et al. Serum levels of cytokines in patients envenomed by Tityus serrulatus scorpion sting. Toxicon. Aug 1999;37(8):1155-64. [Medline].
Malhotra KK, Mirdehghan CM, Tandon HD. Acute renal failure following scorpion sting. Am J Trop Med Hyg. May 1978;27(3):623-6. [Medline].
Muller GJ. Scorpionism in South Africa. A report of 42 serious scorpion envenomations. S Afr Med J. Jun 1993;83(6):405-11. [Medline].
Murthy KR, Hase NK. Scorpion envenoming and the role of insulin. Toxicon. Sep 1994;32(9):1041-4. [Medline].
Naqvi R, Naqvi A, Akhtar F, Rizvi A. Acute renal failure developing after a scorpion sting. Br J Urol. Aug 1998;82(2):295. [Medline].
Nouira S, Boukef R, Nciri N, et al. A clinical score predicting the need for hospitalization in scorpion envenomation. Am J Emerg Med. May 2007;25(4):414-9. [Medline].
Otero R, Navio E, Cespedes FA, et al. Scorpion envenoming in two regions of Colombia: clinical, epidemiological and therapeutic aspects. Trans R Soc Trop Med Hyg. Dec 2004;98(12):742-50. [Medline].
Radmanesh M. Androctonus crassicauda sting and its clinical study in Iran. J Trop Med Hyg. Oct 1990;93(5):323-6. [Medline].
Radmanesh M. Cutaneous manifestations of the Hemiscorpius lepturus sting: a clinical study. Int J Dermatol. Jul 1998;37(7):500-7. [Medline].
Rajarajeswari G, Sivaprakasam S, Viswanathan J. Morbidity and mortality pattern in scorpion stings. (A review of 68 cases). J Indian Med Assoc. Oct 1979;73(7-8):123-6. [Medline].
Reddy CR, Suvarnakumari G, Devi CS, Reddy CN. Pathology of scorpion venom poisoning. J Trop Med Hyg. May 1972;75(5):98-100. [Medline].
Sofer S. Scorpion envenomation. Intensive Care Med. Aug 1995;21(8):626-8. [Medline].
Sundararaman T, Olithselvan M, Sethuraman KR, Narayan KA. Scorpion envenomation as a risk factor for development of dilated cardiomyopathy. J Assoc Physicians India. Nov 1999;47(11):1047-50. [Medline].
Tu A, ed. Handbook of Natural Toxins: Invertebrate Venoms. Vol 2. New York, NY: Marcel Dekker; 1984:513-678.
Velasco-Castrejon O, Lara-Aguilera R, Alatorre H. [Clinical and epidemiological aspects of scorpion sting in a hyperendemic area]. Rev Invest Salud Publica. Apr-Jun 1976;36(2):93-103. [Medline].
Print
